Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2022-08-26 Purchase |
2022-08-30 4:45 pm |
OptimizeRx Corp | OPRX | Odence-Ford Marion General Counsel and CCO |
1,000 | $15.75 | $15,750 | 5,000 (Direct) |
View |
| 2022-08-19 Purchase |
2022-08-23 4:45 pm |
OptimizeRx Corp | OPRX | Lang James Paul Director |
6,000 | $16.45 | $98,723 | 38,660 (Direct) |
View |
| 2022-08-19 Purchase |
2022-08-23 4:45 pm |
OptimizeRx Corp | OPRX | FEBBO WILLIAM J CEO |
16,100 | $15.59 | $251,005 | 461,772 (Direct) |
View |
| 2022-08-16 Purchase |
2022-08-17 4:46 pm |
OptimizeRx Corp | OPRX | Silvestro Stephen L CCO |
3,200 | $15.66 | $50,112 | 3,200 (Direct) |
View |
| 2022-08-16 Purchase |
2022-08-17 4:45 pm |
OptimizeRx Corp | OPRX | Vos Ellen O'Connor Director |
500 | $15.91 | $7,955 | 500 (Direct) |
View |
| 2022-08-15 Purchase |
2022-08-17 4:45 pm |
OptimizeRx Corp | OPRX | Stelmakh Edward CFO/COO |
3,000 | $15.43 | $46,290 | 3,000 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2023-03-01 Tax Withholding |
2023-03-03 3:40 pm |
N/A N/A |
OptimizeRx Corp | OPRX | Silvestro Stephen L Chief Commercial Officer |
668 | $18.11 | 8,314 (Direct) |
View |
| 2023-03-01 Exercise |
2023-03-03 3:40 pm |
N/A N/A |
OptimizeRx Corp | OPRX | Silvestro Stephen L Chief Commercial Officer |
1,927 | $0 | 8,314 (Direct) |
View |
| 2023-03-01 Tax Withholding |
2023-03-03 3:31 pm |
N/A N/A |
OptimizeRx Corp | OPRX | Inman Todd Chief Technology Officer |
233 | $18.11 | 2,080 (Direct) |
View |
| 2023-03-01 Exercise |
2023-03-03 3:31 pm |
N/A N/A |
OptimizeRx Corp | OPRX | Inman Todd Chief Technology Officer |
771 | $0 | 2,080 (Direct) |
View |
| 2023-02-11 Tax Withholding |
2023-02-14 11:32 am |
N/A N/A |
OptimizeRx Corp | OPRX | Odence-Ford Marion General Counsel and CCO |
1,422 | $17.34 | 20,653 (Direct) |
View |
| 2023-02-11 Exercise |
2023-02-14 11:32 am |
N/A N/A |
OptimizeRx Corp | OPRX | Odence-Ford Marion General Counsel and CCO |
4,000 | $0 | 20,653 (Direct) |
View |
| 2023-01-07 Exercise |
2023-01-31 4:50 pm |
N/A N/A |
OptimizeRx Corp | OPRX | FEBBO WILLIAM J CEO |
9,628 | $0 | 481,028 (Direct) |
View |
| 2022-12-30 Exercise |
2023-01-04 4:10 pm |
N/A N/A |
OptimizeRx Corp | OPRX | HALAS GUS D Director |
409 | $0 | 65,571 (Direct) |
View |
| 2022-12-30 Exercise |
2023-01-04 4:07 pm |
N/A N/A |
OptimizeRx Corp | OPRX | WASSON GREGORY D Director |
409 | $0 | 18,674 (Direct) |
View |
| 2022-12-30 Exercise |
2023-01-04 4:06 pm |
N/A N/A |
OptimizeRx Corp | OPRX | Vos Ellen O'Connor Director |
409 | $0 | 34,133 (Direct) |
View |
| 2022-12-30 Exercise |
2023-01-04 4:04 pm |
N/A N/A |
OptimizeRx Corp | OPRX | Spangler Patrick D Director |
409 | $0 | 16,826 (Direct) |
View |
| 2022-12-30 Exercise |
2023-01-04 4:04 pm |
N/A N/A |
OptimizeRx Corp | OPRX | Lang James Paul Director |
409 | $0 | 39,403 (Direct) |
View |
| 2022-11-08 Tax Withholding |
2022-11-10 3:29 pm |
N/A N/A |
OptimizeRx Corp | OPRX | Odence-Ford Marion General Counsel and CCO |
710 | $14.52 | 9,645 (Direct) |
View |
| 2022-11-08 Exercise |
2022-11-10 3:29 pm |
N/A 2024-11-08 |
OptimizeRx Corp | OPRX | Odence-Ford Marion General Counsel and CCO |
1,785 | $0 | 9,645 (Direct) |
View |
| 2022-10-03 Option Award |
2022-10-05 1:18 pm |
N/A N/A |
OptimizeRx Corp | OPRX | Silvestro Stephen L Chief Commercial Officer |
59,002 | $0 | 59,002 (Direct) |
View |
| 2022-10-03 Option Award |
2022-10-05 1:17 pm |
N/A N/A |
OptimizeRx Corp | OPRX | Stelmakh Edward CFO/COO |
147,504 | $0 | 147,504 (Direct) |
View |
| 2022-10-03 Option Award |
2022-10-05 1:15 pm |
N/A N/A |
OptimizeRx Corp | OPRX | Odence-Ford Marion General Counsel and CCO |
59,002 | $0 | 59,002 (Direct) |
View |
| 2022-10-03 Option Award |
2022-10-05 1:14 pm |
N/A N/A |
OptimizeRx Corp | OPRX | Besch Doug Chief Product Officer |
29,500 | $0 | 29,500 (Direct) |
View |
| 2022-10-03 Option Award |
2022-10-05 1:13 pm |
N/A N/A |
OptimizeRx Corp | OPRX | Inman Todd Chief Technology Officer |
29,500 | $0 | 29,500 (Direct) |
View |
Ownership |
2022-10-03 2:57 pm |
N/A N/A |
OptimizeRx Corp | OPRX | Besch Doug Chief Product Officer |
0 | $0 | 16,500 (Direct) |
View |
| 2022-09-29 Exercise |
2022-09-30 4:48 pm |
N/A N/A |
OptimizeRx Corp | OPRX | Spangler Patrick D Director |
334 | $0 | 16,417 (Direct) |
View |
| 2022-09-29 Exercise |
2022-09-30 4:46 pm |
N/A N/A |
OptimizeRx Corp | OPRX | Lang James Paul Director |
334 | $0 | 38,994 (Direct) |
View |
| 2022-09-29 Exercise |
2022-09-30 4:44 pm |
N/A N/A |
OptimizeRx Corp | OPRX | HALAS GUS D Director |
334 | $0 | 65,162 (Direct) |
View |
| 2022-09-29 Exercise |
2022-09-30 4:39 pm |
N/A N/A |
OptimizeRx Corp | OPRX | WASSON GREGORY D Director |
334 | $0 | 18,265 (Direct) |
View |
| 2022-09-29 Exercise |
2022-09-30 4:37 pm |
N/A N/A |
OptimizeRx Corp | OPRX | Vos Ellen O'Connor Director |
334 | $0 | 33,724 (Direct) |
View |
| 2022-06-09 Option Award |
2022-06-13 4:45 pm |
N/A N/A |
OptimizeRx Corp | OPRX | Vos Ellen O'Connor Director |
4,637 | $0 | 4,637 (Direct) |
View |
| 2022-06-09 Option Award |
2022-06-13 4:45 pm |
N/A N/A |
OptimizeRx Corp | OPRX | Spangler Patrick D Director |
4,637 | $0 | 4,637 (Direct) |
View |
| 2022-06-09 Option Award |
2022-06-13 4:45 pm |
N/A N/A |
OptimizeRx Corp | OPRX | Lang James Paul Director |
4,637 | $0 | 4,637 (Direct) |
View |
| 2022-06-09 Option Award |
2022-06-13 4:45 pm |
N/A N/A |
OptimizeRx Corp | OPRX | HALAS GUS D Director |
4,637 | $0 | 4,637 (Direct) |
View |
| 2022-06-09 Option Award |
2022-06-13 4:45 pm |
N/A N/A |
OptimizeRx Corp | OPRX | WASSON GREGORY D Director |
4,637 | $0 | 4,637 (Direct) |
View |
| 2022-03-30 Option Award |
2022-04-01 4:48 pm |
N/A N/A |
OptimizeRx Corp | OPRX | Spangler Patrick D Director |
657 | $0 | 657 (Direct) |
View |
| 2022-03-30 Option Award |
2022-04-01 4:48 pm |
N/A N/A |
OptimizeRx Corp | OPRX | Lang James Paul Director |
657 | $0 | 657 (Direct) |
View |
| 2022-03-30 Option Award |
2022-04-01 4:47 pm |
N/A N/A |
OptimizeRx Corp | OPRX | HALAS GUS D Director |
657 | $0 | 657 (Direct) |
View |
| 2022-03-30 Option Award |
2022-04-01 4:46 pm |
N/A N/A |
OptimizeRx Corp | OPRX | Vos Ellen O'Connor Director |
657 | $0 | 657 (Direct) |
View |
| 2022-03-30 Option Award |
2022-04-01 4:45 pm |
N/A N/A |
OptimizeRx Corp | OPRX | WASSON GREGORY D Director |
657 | $0 | 657 (Direct) |
View |
| 2022-03-01 Option Award |
2022-03-03 4:46 pm |
N/A 2027-03-01 |
OptimizeRx Corp | OPRX | Inman Todd Chief Technology Officer |
7,003 | $0 | 7,003 (Direct) |
View |
| 2022-03-01 Option Award |
2022-03-03 4:46 pm |
N/A 2027-03-01 |
OptimizeRx Corp | OPRX | Silvestro Stephen L Chief Commercial Officer |
17,508 | $0 | 17,508 (Direct) |
View |